Table 3 Multivariate analysis of the impact of variables on biochemical recurrence-free survival and overall survival in PCa patients
Variable | P | Odds ratio |
|---|---|---|
Overall survival | ||
Clinical stage | ||
T1 + T2 vs. T3 + T4 | 0.006 | 6.98 |
Gleason score | ||
<7 vs. ≥7 | 0.03 | 2.82 |
Metastasis | ||
Negative vs. positive | 0.01 | 4.16 |
Rab25 expression | ||
Low vs. high | 0.02 | 3.09 |
Biochemical recurrence-free survival | ||
Clinical stage | ||
T1 + T2 vs. T3 + T4 | 0.01 | 4.09 |
Gleason score | ||
<7 vs. ≥7 | 0.03 | 2.50 |
Metastasis | ||
Negative vs. positive | 0.01 | 4.38 |
Rab25 expression | ||
Low vs. high | 0.03 | 2.28 |